Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
- PMID: 38855152
- PMCID: PMC11154675
- DOI: 10.3748/wjg.v30.i20.2633
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
Abstract
This editorial builds on the article titled "Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease" by Zeng et al. We carried out a critical examination of nonalcoholic fatty liver disease (NAFLD) pathogenesis and how lifestyle interventions could facilitate disease resolution, particularly highlighting that non-alcoholic steatohepatitis (NASH) is a severe form of NAFLD. Our discussion details that weight loss is a pivotal factor in disease outcomes: A 3%-5% reduction is enough for resolution in 50% of non-obese individuals, while a 7%-10% reduction achieves similar benefits in obese individuals, as demonstrated by magnetic resonance spectroscopy. Additionally, the editorial underscores that such lifestyle changes are instrumental not only in resolving NAFLD but also in reversing hepatic steatosis and inflammation. These insights, derived from the research, emphasize the critical role of personalized lifestyle modifications in halting the progression of NAFLD to NASH and even reversing fibrosis, thus offering a template for effective patient management.
Keywords: Diet; Life style; Non-alcoholic steatohepatitis; Nonalcoholic fatty liver disease; Physical activity.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Similar articles
-
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need.World J Gastroenterol. 2024 Jul 7;30(25):3143-3146. doi: 10.3748/wjg.v30.i25.3143. World J Gastroenterol. 2024. PMID: 39006382 Free PMC article.
-
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G329-G338. doi: 10.1152/ajpgi.00044.2018. Epub 2018 Jun 7. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 29878845
-
Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research.Digestion. 2019;100(2):79-85. doi: 10.1159/000493259. Epub 2018 Dec 7. Digestion. 2019. PMID: 30537758 Review.
-
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.Gastroenterology. 2021 Feb;160(3):912-918. doi: 10.1053/j.gastro.2020.11.051. Epub 2020 Dec 9. Gastroenterology. 2021. PMID: 33307021 Review.
-
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 30653341
Cited by
-
Targeting Metabolism: Innovative Therapies for MASLD Unveiled.Int J Mol Sci. 2025 Apr 25;26(9):4077. doi: 10.3390/ijms26094077. Int J Mol Sci. 2025. PMID: 40362316 Free PMC article. Review.
-
MRI-PDFF Assessment of Intrahepatic Fat Changes Post-Bariatric Surgery: A Systematic Literature Review.Medicina (Kaunas). 2024 Dec 4;60(12):2003. doi: 10.3390/medicina60122003. Medicina (Kaunas). 2024. PMID: 39768883 Free PMC article.
-
Delaying liver aging: Analysis of structural and functional alterations.World J Gastroenterol. 2025 Apr 21;31(15):103773. doi: 10.3748/wjg.v31.i15.103773. World J Gastroenterol. 2025. PMID: 40309235 Free PMC article.
-
Healthy Lifestyle and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study of the Efficacy of Fatty Liver Regression.Clin Transl Gastroenterol. 2025 Feb 1;16(2):e00806. doi: 10.14309/ctg.0000000000000806. Clin Transl Gastroenterol. 2025. PMID: 39729093 Free PMC article. Clinical Trial.
References
-
- Ahmed MH, Noor SK, Bushara SO, Husain NE, Elmadhoun WM, Ginawi IA, Osman MM, Mahmoud AO, Almobarak AO. Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System. Gastroenterology Res. 2017;10:271–279. - PMC - PubMed
-
- Giraudi PJ, Stephenson AM, Tiribelli C, Rosso N. Novel high-throughput applications for NAFLD diagnostics and biomarker discovery. Hepatoma Res. 2021
-
- Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537–2564. - PubMed